A study identified the cell-surface adhesion receptor CD44 as a key positive regulator of PD-L1 expression in triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)45. This evidence concerns the gene CD44 and non-small cell lung carcinoma.